Hemangiopericytoma of the nasal septum

Navarrete, Mayda; Maeso, Jordi; Pellicer, Marc

doi:10.1007/bf00179014

Cited by 8 publications

(6 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This vascular neoplasm firstly described in 1943 by Stout and Murray [1] may arise in any part of the body [2]; only 15%–30% are located in the head and neck region [3]. Of these, only 5% are found in the nasal cavity and paranasal sinus [4].…”

Section: Introductionmentioning

confidence: 99%

Endoscopic Resection of Sinonasal Hemangiopericytoma following Preoperative Embolisation: A Case Report and Literature Review

Ledderose

Gellrich

Holtmannspötter

et al. 2013

Case Reports in Otolaryngology

View full text Add to dashboard Cite

Objectives. Hemangiopericytoma is a rare tumor entity deriving from pericytes. Less than 5% of hemangiopericytoma occur in the nasal cavity and are characterised by a rather benign nature with low tendency of metastasis. However, as the recurrence rate in the literature ranges from 9.5% to 50%—depending on the length of followup—a radical surgical resection is considered as the gold-standard treatment. Only a few years ago, a wide external approach, usually via lateral rhinotomy or Caldwell-Luc, was performed. Endoscopic techniques were regarded as appropriate for small low-vascularised tumors only. Methods. We present the case of a 64-year-old patient with an extended sinonasal hemangiopericytoma, who was successfully treated by an endoscopic controlled endonasal tumor resection after embolisation with Onyx. Further, to support the new treatment option, we review the literature concerning all features of sinonasal hemangiopericytomas and their therapeutical management. Results/Conclusion. Onyx, which has not been described in the context of hemangiopericytoma yet, is a very effective embolic agent for a preoperative embolisation of sinonasal hemangiopericytoma allowing a safe endoscopic surgery.

show abstract

Section: Introductionmentioning

confidence: 99%

Endoscopic Resection of Sinonasal Hemangiopericytoma following Preoperative Embolisation: A Case Report and Literature Review

Ledderose

Gellrich

Holtmannspötter

et al. 2013

Case Reports in Otolaryngology

View full text Add to dashboard Cite

show abstract

“…3 They are thought to be derived from extra-capillary cells, the pericytes, which, in these tumours, surround normal vascular channels. They are found throughout the body 4 with less than one third occurring in the head and neck. 1 ,5 ,6 Of these, only ve per cent are located in the nasal cavity and paranasal sinuses, 2 ,7 with a predilection for the nasal cavity, and the ethmoid and sphenoid sinuses.…”

Section: Introductionmentioning

confidence: 99%

Endoscopic sinus surgery for sinonasal haemangiopericytomas

et al. 2002

View full text Add to dashboard Cite

Haemangiopericytomas are rare peri-vascular tumours with variable malignant potential. The nasal cavity and the paranasal sinuses are most often involved in the head and neck. Five cases of haemangiopericytomas treated by a strict endonasal endoscopic approach are presented. Bleeding and nasal obstruction are the most frequent symptoms. Computed tomography (CT) scan and magnetic resonance imaging (MRI) allowed pre-operative assessment. Angiography with embolization was needed in two of the five cases. None of our patients presented with malignant histology. Our five cases were operated on, and a total tumour excision was performed through the endoscopic endonasal approach. We had one recurrence with a mean follow-up of 4.5 years. We suggest that when the tumour is purely intranasal or strictly located in the ethmoid or sphenoid sinus, it can be removed via an endonasal approach under endoscopic guidance in experienced hands.

show abstract

“…After full‐text assessment, 139 articles were also excluded: articles containing no histologic findings (n = 20), unclear histology (n = 10), duplicate cases (n = 3), cases not arising in the sinonasal tract (n = 21), other sinonasal tumors, such as solitary fibrous tumor (n = 39), glomus tumor (n = 27), myopericytoma (n = 3), fibroma (n = 1), papilloma (n = 1), and lymphoma (n = 1), and reviews without information about individual cases (n = 13). Finally, 80 articles containing glomangiopericytoma of the sinonasal tract (337 cases) were identified as eligible for this study . Most articles (75/80; 94%) were published in English, except for 5 articles written in Korean …”

Section: Resultsmentioning

confidence: 99%